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The objective of the present study was to evaluate the possible protective effects of Tribulus 
terrestris fruit aqueous extract (TTFAEt) on lipid profile and oxidative stress in isoproterenol 
(ISO) induced myocardial necrosis in albino Wistar rats. Albino Wistar rats were divided into 
normal control, TTFAEt alone treated, ISO control and pretreated (TTFAEt+ISO) groups. 
The extract was administered at a dose of 50 mg/kg body weight for 40 days orally by gavage 
and ISO was administered at a dose of 85 mg/kg body weight for two consecutive days intra-
peritoneally at an interval of 24 h. ISO induced myocardial infarction (MI) was confirmed by 
disturbances in serum lipid profile, heart tissue lipid peroxidation and antioxidant enzyme 
levels. There was a significant increase in the levels of serum total cholesterol (32.60 %), tri-
glycerides (41.30 %), very low density lipoproteins (81.81 %), low density lipoproteins (84%) 
and phospholipids (38.88 %) and a significant decrease in the levels of high density lipopro-
teins (33.33 %) in the ISO control group when compared to normal controls. Additionally, 
there is a significant decrease in the levels of heart tissue antioxidant enzymes such as super-
oxide dismutase, catalase, glutathione reductase, glutathione peroxidase and depletion of re-
duced glutathione, which indicates enhanced lipid peroxidation(172 %). Pretreatment with 
extract significantly showed a protective effect against ISO altered lipid profile, lipid peroxi-
dation and antioxidant enzyme levels. The present study showed therapeutic effect of TTFAEt 
on lipid profile and oxidative stress in isoproterenol (ISO) induced myocardial necrosis in ex-
perimental rats. 
 





Cardiovascular diseases (CVDs) remain 
the principle cause of death in both devel-
oped and developing countries, accounting 
roughly 20 % of all deaths worldwide an-
nually. Among various CVDs, myocardial 
infarction (MI) or heart attack is the leading 
cause of morbidity and mortality and major 
cause of death by the year 2020 worldwide. 
MI occurs when the blood supply to a part 
of the heart is interrupted, causing death of 
heart tissue. It means necrosis of a region of 
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myocardium, usually as a result of occlu-
sion of a coronary artery (Upaganlawar et 
al., 2011). It is most probably induced by 
catecholamine metabolism in particular re-
dox reactions that results in aminochromes 
and adrenochromes (Dhalla et al., 2000). 
These oxidative reactions produce free rad-
ical (Rupp et al., 1994). 
Isoproterenol (ISO) (L-β-(3,4-dihydro-
xyphenyl)-α-isopropylaminoethanol hydro-
chloride), a synthetic catecholamine, is a β-
adrenergic agonist that causes severe stress 
in myocardium resulting in the infarct like 
necrosis of heart muscle (Osadchii et al., 
2007). ISO develops many metabolic and 
morphological aberrations in the heart tis-
sue of the experimental animals similar to 
those observed in human MI (Nirmala and 
Puvanakrishnan, 1996). Due to oxidative 
metabolism ISO causes excessive produc-
tion of free radicals which induce lipid per-
oxidation (LPO) that causes irreversible 
damage to the myocardial membrane 
(Sathish et al., 2003; Mohanthy et al., 
2004). ISO also causes an increase in the 
levels of circulatory and myocardial lipids 
indicating its hyperlipidemic effect. 
Tribulus terrestris L., deciduous herb of 
the Zygophyllaceae family, is an important 
herb from Indian and Chinese traditional 
medicine literature for the treatment of var-
ious diseases especially ischemic heart dis-
eases (Warrier et al., 1996). It also has hy-
poglycemic,hypolipidemic, nephroprotec-
tive, aphrodisiac and immunomodulator 
activities. The major therapeutic values of 
the extract are antihypertensive, cardiopro-
tective and anti-inflammatory activity. In 
addition, the plant is used with 0.4 % com-
position in preparation of bramha rasayana 
as one of the component. We have taken up 
the present study to evaluate the cardiopro-
tective effect of TTFAEt on lipid profile 
and oxidative stress in isoproterenol in-
duced MI.  
 
MATERIALS AND METHODS 
Chemicals 
The chemicals used in the current study 
were procured from Sigma Chemical Com-
pany (St. Louis, MO, USA), and SISCO 




The fresh fruits of plant material were 
collected in and around Sri Krishnade-
varaya University, Anantapur, Andhra Pra-
desh, India and identified by a Taxonomist 
and preserved in the Department of Botany. 
 
Preparation of plant extract 
After the collection of fresh fruits of 
Tribulus terrestris, they were air dried and 
dried fruits are fine powdered. 100 gms of 
powder was infused in distilled water until 
1 complete exhaustion. The extract was 
then filtered using Whatman No. 1 filter 
paper and the filtrate was evaporated in 
vacuo and dried using rotary evaporator at 
60 °C (Kandil et al., 1994). The dried ex-
tract was stored in sterile bottles until fur-
ther use. 
 
Animal ethical clearance 
Local Institutional Animal Ethical 
Committee of our University, obtained eth-
ical clearance for conducting experiments 
on animals from Committee for the Purpose 
of Control and Supervision of Experiments 
on Animals (CPCSEA) (Reg. no. 470/01/a/ 
CPCSEA, dt. 24th Aug 2001). The present 
work was carried out with a prior permis-
sion from Local Institutional Animal Ethi-
cal Committee.  
 
Induction of cardiac stress in rat 
Cardiac stress was induced in rats by 
i.p. injection of ISO at a dose of 85 mg/kg 
body weight for two consecutive days at an 
interval of 24 h. ISO was first weighed in-
dividually in eppendorf tubes for each ani-
mal according to the weight and then solu-
bilized, just prior to injection in 0.1 ml of 
distilled water.  
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In the present study the rats were divid-
ed into four groups of six rats each:  
 Normal control; 
 TTFAEt alone treated (50 mg/kg body 
weight for 40 days);  
 ISO control: (85 mg/kg body weight, 
once a day for two days);  
 Pretreated: (TTFAEt+ISO) (50 mg/kg 
body weight for 40 days and then i.p. 
injected with ISO (85 mg/kg body 
weight, once a day for two days)).  
The extract dose was fixed according to 
previous literature. Intubation was accom-
plished by means of a slightly bend steel 
intubation needle with ball like thickening 
terminal, attached to a syringe and extract 
was infused down the food pipe. 
 
Blood collection and serum separation 
Blood was collected in Eppendorf tubes 
from 12 h fasted rats by means of capillary 
tube through retinorbital flexus after second 
dose of ISO administration. The blood col-
lected without added anticoagulant was al-
lowed to clot for 30 min and serum was 
separated by centrifugation and used for the 
analysis of lipid profile. 
 
 Animal sacrifice and organ collection 
After the experimental period, animals 
were sacrificed by cervical dislocation and 
immediately hearts were removed and 
washed thoroughly with ice-cold 0.89 % 
NaCl (saline). Heart of every animal was 
suspended in 0.15 M KCl and 10 % ho-
mogenate of heart was prepared using Pot-
ter-Elvehjem homogenizer at 0 oC in 0.1 M 
Tris HCl. The whole homogenate was used 
for estimation of reduced glutathione 
(GSH) and LPO. The homogenate was cen-
trifuged in cooling centrifuge at 12000 rpm 
for 45 min at 0-4 oC to remove the debris 
and supernatant was used for antioxidant 
enzyme assays. 
 
Estimation of serum lipid profile 
Serum cholesterol and triglycerides 
were estimated using Accurex enzymatic 
diagnostic kit and HDL-cholesterol was es-
timated by using Autozyme cholesterol di-
agnostic kit.  
 
Total cholesterol(TC) 
Cholesterol esterase and cholesterol ox-
idase converts cholesterol esters into free 
cholesterol, fatty acids, cholest-4-en-3-one 
and hydrogen peroxide. In addition, hydro-
gen peroxide oxidatively couples with 4-
aminoantipyrine and phenol to produce red 
quinoneimine dye which has absorbance 
maximum at 510 nm.The intensity of the 
red colour is proportional to the amount of 
total cholesterol (Allain et al., 1974). The 
assay system contains Accurex Infinite cho-
lesterol liquid 50 mM buffer pH 6.8, cho-
lesterol oxidase 100 IU/L, cholesterol ester-
ase 150 IU/L, peroxidase 500 IU/L, 4-
aminoantipyrine 0.5 mM, phenol 0.5 mM 
and cholesterol standard (200 mg%). To 
0.01 ml of serum, 1.0 ml of the reagent was 
added, mixed and incubated at 37 ˚C for 
10 min. Cholesterol standard and blank 
were also treated in a similar manner. After 
incubation, absorbance was read at 510 nm 
and values are expressed as mg/dL. 
 
Triglycerides (TG) 
Glycerol released from hydrolysis of 
TG by lipoprotein lipase is converted by 
glycerol kinase into glycerol-3-phosphate, 
which is oxidized by glycerol phosphate 
oxidase to dihydroxyacetone phosphate and 
hydrogen peroxide. In presence of peroxi-
dase, hydrogen peroxide oxidizes phenolic 
chromogen to a red coloured compound 
which is measured at 510 nm (Fossati et al., 
1982). The assay mixture consists of lipase 
≥ 4 KU/L, glycerol kinase ≥ 40 U/L, gly-
cerol phosphate oxidase≥ 5 KU/L, peroxi-
dase ≥ 820 U/L, triglyceride standard 
200 mg%. To 0.01 ml of serum, 1.0 ml of 
the reagent was added, mixed and incubated 
at 37 °C for 10 min.Triglyceride standard 
and water blank were also treated in a simi-
lar manner. After incubation, absorbance of 
the standard and serum was read at 510 nm 
against blank and values are expressed as 
mg/dL. 
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The assay mixture consists of trichloro-
acetic acid (TCA) 5 %,perchloric acid 
70 %, conc. H2SO4 3N, sodium acetate 
50 %, ammonium molybdate 2.5 %, ami-
nonapthosulphonic acid (ANSA) 0.5 gm, 
sodium bisulphate 15 %, sodium sulphate 
20 %. PL precipitate was obtained in 0.2 ml 
of serum by the addition of 5 ml 5 % (w/v) 
TCA, 1 ml of digestion mixture (50 ml dis-
tilled water, 25 ml of 70 % perchloric acid, 
25 ml conc.H2SO4) and heated gently for 
about 30-45 min until the liquid becomes 
colourless. It was cooled,1 ml of distilled 
water was added, allowed to boil for 15 sec 
to convert pyrophosphate to orthophos-
phate.1 ml of 50 % sodium acetate was 
added and phosphorus was estimated by 
Fiske Subbarow method. To the above di-
gest, 1 ml of molybdate-II reagent (2.5 % 
ammonium molybdate in 3N H2SO4), 
0.4 ml of ANSA reagent (0.5 gms of α-
ANSA in 195 ml of 15 % sodium bisul-
phate and 5 ml of 20 % sodium sulphate) 
was added and volume was made up to 
10 ml with distilled water and absorbance 
was read in spectrophotometer at 
680 nm.Potassium dihydrogen phosphate is 
used as a standard, concentration ranging 
from 4-80 μg, to which 1 ml of molybdate-I 
reagent (2.5 % of ammonium molybdate in 
5N H2SO4), 0.4 ml of ANSA reagent were 
added and the volume was made up to 
10 ml with distilled water and the absorb-
ance was read in spectrophotometer at 
680 nm. 
 
Very low density lipoprotein and 
low density lipoprotein 
VLDL and LDL were calculated using 
the Friedewald et al. (1972) formula as fol-
lows:  
 VLDL =TG/5 
 LDL =TC - TG/5 +HDL. 
 
High density lipoprotein cholesterol 
(HDL) 
Phosphotungstate/Mg2+ precipitate chy-
lomicrons, LDL fractions and HDL fraction 
remains uneffected in supernatant. Choles-
terol content of HDL fraction is assayed 
using Autozyme cholesterol diagnostic kit 
(Assmann et al., 1983). The assay mixture 
consists of 2.4 mM phosphotungstic acid, 
40 mM magnesium chloride, Autozyme 
HDL cholesterol working solution. To 
0.2 ml of serum, 0.2 ml of precipitant rea-
gent was added, mixed and centrifuged at 
4,000 rpm for 10 min to obtain a clear su-
pernatant.To 0.05 ml of supernatant, 1.0 ml 
of autozyme of HDL cholesterol working 
solution was added, incubated for 10 min at 
37 ˚C and colour developed was read at 
510 nm against a blank and a standard 
(50 mg%) was run simultaneously. Values 
are expressed as mg/dL. 
 
Lipid peroxidation 
LPO in the heart tissue was determined 
by assaying malondialdehyde (MDA) for-
mation according to method of Utley et al. 
(1967). To 1 ml of the heart homogenate, 
2 ml of TCA and 4 ml of TBA were added, 
heated in a water bath for 30 minutes.After 
cooling and centrifugation, the absorbance 
of the supernatant was read at 535 nm. A 
reagent blank was prepared using water in-
stead of tissue homogenate.The extent of 
LPO was expressed as nmole MDA 
formed/mg protein, using a molar extinc-
tion co-efficient of MDA as 1.56x105 M-1 
cm-1. 
 
Superoxide dismutase (SOD) 
SOD activity was measured based on 
the ability of the enzyme to inhibit the auto-
oxidation of pyrogallol.A modified proce-
dure described by Marklund and Marklund 
(1974) was adopted as followed by Soon 
and Tan (2002). The assay system con-
tained 2.1 ml of buffer, 0.02 ml of enzyme 
source (35 µg protein) and 0.86 ml of dis-
tilled water. The reaction was initiated with 
0.02 ml of pyrogallol and change in absorb-
ance was monitored at 420 nm. The percent 
inhibition was calculated on the basis of 
comparison with a blank assay system.One 
unit of SOD was defined as that amount of 
enzyme required to inhibit the auto-
oxidation of pyrogallol by 50 % in standard 
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assay system of 3 ml.The specific activity 
was expressed as units/min/mg protein read 
in spectrophotometer.  
 
Catalase (CAT) 
Catalase catalyses the break down of H2O2 
to H2O and O2 and the rate of decomposi-
tion of H2O2 was measured spectrophoto-
metrically at 240 nm following the method 
of Beers and Sizer (1952). The assay sys-
tem contained 1.9 ml sodium phosphate 
buffer (0.05 M, pH 7.0), and 1.0 ml H2O2. 
The reaction was initiated by addition of 
0.1 ml enzyme source (45 µg protein).The 
decrease in absorbance was monitored at 
1 min interval for 5 min at 240 nm and ac-
tivity was calculated using a molar absorb-
ance index of H2O2. The activity was ex-
pressed as nmoles of H2O2 decom-
posed/min/mg protein. 
 
Reduced glutathione (GSH) 
Total GSH content was measured by 
following Ellman’s method (1959). This 
method was based on the development of a 
yellow colour, when 5,5’-dithio-bis(2-nitro 
benzoic acid) (DTNB) reacts with the com-
pounds containing sulphydryl groups with a 
maximum absorbance at 412 nm. 0.5 ml of 
heart tissue homogenate was deproteinized 
with 3.5 ml of 5 % TCA and centrifuged. 
To 0.5 ml of supernatant, 3.0 ml phosphate 
buffer and 0.5 ml of Ellman`s reagent were 
added and the yellow colour developed was 
read at 412 nm.A series of standards (4-
20 µg) were treated in a similar manner 
along with a blank. Values are expressed as 
µg GSH/mg protein. 
 
Glutathione peroxidase (GPx) 
A known amount of the enzyme prepa-
ration was allowed to react with H2O2 in the 
presence of GSH for a specified time period 
according to the method of Rotruck et al. 
(1973) and remaining GSH was measured 
by Ellman’s method (1959). To 0.5 ml 
phosphate buffer, 0.2 ml enzyme source, 
0.2 ml GSH, 0.1 ml H2O2 were added and 
incubated at room temperature for 10 min 
along with a control tube containing all rea-
gents except enzyme source. The reaction 
was arrested by adding 0.5 ml of 10 % 
TCA, centrifuged at 4000 rpm for 5 min 
and GSH content in 0.5 ml of supernatant 
was estimated. The activity was expressed 
as µg of GSH consumed/min/mg protein. 
 
Glutathione reductase(GRx) 
GRx catalyzes the reduction of oxidized 
glutathione(GSSG) by NADPH to GSH. 
The activity of the enzyme was measured 
by following the oxidation of NADPH 
spectrophotometrically at 340 nm according 
to the method of Pinto and Bartley (1969). 
The assay system contained 0.50 ml of po-
tassium phosphate buffer (0.25 M, pH 7.4), 
1.0 ml of EDTA, 0.10 ml of NADPH, 
0.96 ml of distilled water and 0.10 ml of 
enzyme source (150 µg proteins). The reac-
tion was initiated by addition of 0.24 ml of 
GSSG. The change in absorbance was re-
corded at 1 min intervals at 340 nm for 
5 min. The specific activity was expressed 
as mol of NADPH oxidized/min/mg pro-
tein using an extinction coefficient for 
NADPH of 6.22 cm-1 µmol-1. 
 
Glutathione-S-transferase (GST) 
GST activity was measured by monitor-
ing the increase in the absorbance at 
340 nm using 1-chloro-2,4-dinitrobenzene 
(CDNB) as a substrate according to the 
method of (Habig et al., 1974).The assay 
system contained 1.7 ml of sodium phos-
phate buffer (0.14 M, pH 6.5), 0.2 ml GSH 
and 0.04 ml enzyme source (40 µg protein). 
The reaction was initiated by 0.06 ml 
CDNB.The change in absorbance was rec-
orded at 1 min intervals at 340 nm for 
5 min and the activity was calculated using 
an extinction coefficient of CDNB-GSH 
conjugate as 9.6 mM-1 and expressed as 
mmoles of CDNB-GSH conjugate formed/ 
min/mg protein. 
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General observation and characteristics 
No visible side effects and variations in 
animal behavior were observed when the 
extract is administered for 40 days, indicat-
ing the non-toxic nature of TTFAEt. 
 
Effect of TTFAEt on serum lipid profile 
Table 1 shows a significant increase 
(p<0.05) in the levels of serum TC, TG, 
VLDL, LDL and PL and a significant de-
crease in HDL-C in rats administered with 
ISO when compared to normal control 
group. Pretreatment with TTFAEt showed 
decreased levels of serum TC, TG, VLDL, 
LDL and PL and a concomitant increase in 
the levels of serum HDL in comparison to 
the ISO control group. 
 
Effect of TTFAEt on oxidative stress and 
antioxidant enzymes 
A significant (p<0.05) decrease in myo-
cardial GSH level, along with decrease in 
the activities of glutathione dependent en-
zymes(GPX, GST, GRx), antilipid peroxi-
dative enzymes (SOD and CAT) and in-
crease in lipid peroxidation products in 
heart tissue of ISO administered rats was 
observed in comparison to normal control 
rats (Tables 2 and 3). This indicates de-
creased levels of tissue antioxidant status 
and increased lipid peroxidation in ISO in-
duced myocardial necrosis. Pretreatment 
with TTFAEt significantly (p<0.05) pre-
vented these adverse changes in heart tissue 
and maintained near normal levels. 
 
Statistical analysis 
The results were expressed as mean ± 
S.E.M. Data were analysed for significant 
difference using Duncan’s Multiple Range 




Table 1: Effect of TTFAEt treatment on serum lipid profile in normal and experimental rats 
Parameters NC TTFAEt ISO TTFAEt+ISO 
Total cholesterol 92 ± 4.2a 88  ±  4.7a 124 ± 5.5b 110 ± 3.7c 
Triglycerides 92 ± 0.3 a 96 ± 0.4 a 120 ± 0.8 b 105 ± 0.6c 
Phospholipids 75 ± 1.3 a 70 ± 1.3 a 100 ± 1.2 b 95 ± 1.3c 
Very low density 
lipoproteins 24 ± 0.5
 a 20 ± 0.8 a 37 ± 0.8 b 20 ± 0.5 a 
Low density  
lipoproteins 26 ± 3.4
 a 23 ± 2.1 a 48 ± 3.3b 38 ± 2.6 c 
High density  
lipoproteins 28 ± 1.3
 a 29 ± 2.8 a 20 ± 1.4b 26 ± 1.3 a 
Values are expressed as mean ± S.E.M (n=6). Means with different superscripts within the column are significantly different at 




Table 2: Effect of TTFAEt treatment on lipid peroxidation in normal and experimental rats 
Lipid peroxidation NC TTFAEt ISO TTFAEt+ISO 
nmoles of MDA 
formed/mg of protein 23 ± 1.2
a 23 ± 1.8 a 61 ± 2.4b 34 ± 2.1 c 
Values are expressed as mean ± S.E.M (n=6). Means with different superscripts within the column are significantly different at 
P<0.05 (Duncan’s multiple range test).NC: Normal control, TTFAEt: Control treated with extract, ISO: ISO control, TTFAEt+ISO: 
Pretreated 
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Table 3: Effect of TTFAEt treatment on heart tissue antioxidant enzymes in normal and experimental 
rats 
Parameters NC TTFAEt ISO TTFAEt+ISO 
superoxide dismutase 
(U/min/mg protein) 37.4± 2.5
 a 38.7 ± 3.1 a 25.4 ± 2.3b 31.1 ± 2.0c 
Catalase 
(mmoles of H2O2 
decomposed/min/mg 
protein) 
76.5 ± 2.7 a 71.4 ± 4.3 a 42.6 ± 3.3 b 52.4 ± 2.8c 
Glutathione 
(μg of GSH/mg protein) 6.4 ± 0.4
 a 6.3± 0.5 a 3.7 ± 0.6 b 5.5 ± 0.5 a 
glutathione peroxidase
(moles of GSH con-
sumed/min/mg protein) 
8.5 ± 0.4 a 8.7 ± 0.4 a 3.8 ± 0.6 b 7.6 ± 0.2 a 
glutathione reductase 
(mmoles of NADPH ox-
idized/min/mg protein) 
31.1 ± 4.6 a 29.6 ± 1.7 a 11.7 ± 0.4 b 26.1 ± 0.9c 
glutathione–S–




6.0 ± 0.1 a 5.5 ± 0.4 a 3.0 ± 0.2b 5.0 ± 0.4a 
Values are expressed as mean ± S.E.M (n=6). Means with different superscripts within the column are significantly different at 





Catecholamines at low concentrations 
are considered to be a beneficial in regulat-
ing heart function by exerting a positive 
inotropic effect. Catecholamine administra-
tion at high doses or their excessive release 
from the endogenous stores may deplete the 
energy reserve of cardiomyocytes that re-
sults in biochemical and structural changes 
responsible for the development of irre-
versible damage. 
Lipids play an important role in cardio-
vascular diseases, not only by way of hy-
perlipidemia and the development of ather-
osclerosis, but also by modifying the com-
position, structure and stability of the myo-
cardium. High levels of circulating choles-
terol along with TG and their accumulation 
in the heart tissue is usually accompanied 
by cardiovascular damage (Gokkusu et al., 
2003). Generally, the mechanisms of ac-
tions of lipolytic hormones, including ISO, 
on fat cells are believed to be mediated by 
the cAMP cascade: lipolytic hormones acti-
vate adenylate cyclase, thereby increasing 
cAMP formation. The increased cAMP 
promotes lipolytic activity by activating 
cAMP dependent protein kinase, which 
phosphorylates hormone-sensitive lipase 
(Morimoto et al., 2000) and promotes high-
er lipid accumulation in the myocardium 
(Dhawan et al., 1978) by hydrolysis of 
stored TG. Thus ISO causes an increase in 
the levels of myocardial lipids indicating its 
hyperlipidemic effect (Radhiga et al., 
2012). 
In the present study, ISO evidenced its 
hyperlipidemic effect by increasing serum 
TC, TG, PL, VLDL and LDL levels and 
decreased levels of HDL in comparision 
with normal controls. High levels of LDL 
show positive correlation with MI, while 
increased levels of HDL have a negative 
correlation. Our earlier studies (Kareem et 
EXCLI Journal 2013;12:373-383 – ISSN 1611-2156 




al. 2009) reported hyperlipidemia in ISO 
induced myocardial necrosis. An increase 
in LDL and VLDL, along with a decrease 
in HDL, was observed in ISO induced rats. 
LDL formation occurs primarily in the ca-
tabolism of VLDL. LDL is capable of car-
rying the highest concentration of choles-
terol and PL evidencing increased serum 
TC and PL (Morimoto et al., 2000). Free 
radicals generated by ISO promote LDL 
oxidation and oxidatively modified LDL is 
responsible for the development of athero-
sclerosis. HDL restricts the oxidation of 
LDL, thus preventing the damage to the 
myocardium.  
Pretreatment with TTFAEt significantly 
decreased the increased TC, TG, PL, VLDL 
and LDL levels and increased the levels of 
HDL. This alterations in lipid profile might 
be due to the presence of major active con-
stituents i.e., steroidal saponins, lignana-
mides and tribulosins in TTFAEt (Wang et 
al., 1997). 
Oxidative stress, defined as a shift in the 
normal antioxidant balance, due to the for-
mation of reactive oxygen species (ROS) 
and more probably one of the main mecha-
nism through which catecholamine exert 
their toxic effects. ISO, a synthetic cate-
cholamine induces oxidative stress similar 
to that of other catecholamines on oxidation 
by the generation of toxic reactive oxygen 
species (ROS) such as superoxide radicals, 
hydrogen peroxide radicals and hydroxyl 
radicals (Vaage and Valen, 1993). The 
model of ISO induced myocardial ischemia 
is considered as one of the most widely 
used experimental model to study the bene-
ficial effects of many drugs and cardiac 
function (Wexler, 1978). 
ISO induced oxidative stress rapidly 
generates ROS which plays a key role in 
the development of MI. The induced oxida-
tive stress by spontaneous oxidation of cat-
echolamines resulting in the formation of 
catecholamine-o-quinones, which generate 
aminochromes through cyclisation. While, 
adrenochrome (which results from the cy-
clisation of epinephrine-o-quinone) can be 
oxidized to several other compounds such 
as adrenolutin, 5,6-dihydroxy-1-methylin-
dole (DHMI) or adrenochrome-adrenolutin 
dimer. All these redox reactions generate 
ROS (Upaganlawar et al., 2011). ROS pri-
marily attack poly unsaturated fatty acids 
(PUFA), which is an initiator of lipid per-
oxide formation (Karthika et al.,2011). ISO 
induced oxidative stress enhances LPO. In-
creased myocardial lipid peroxides are sug-
gestive of lipid accumulation and irreversi-
ble myocardial damage. Intense lipid perox-
ides caused by ISO may affect the mito-
chondrial and cytoplasmic membrane caus-
ing more severe oxidative damage in the 
heart and consequently releasing lipid per-
oxides into circulation (Banerjee et al., 
2003). Prior treatment with TTFAEt de-
creased the levels of LPO products in ISO 
induced rats shows its antilipid peroxidation 
effect. 
Free radical scavenging enzymes such 
as CAT, SOD, and GPx are the first line of 
cellular defense against oxidative injury, 
decomposing O2 and H2O2 before their in-
teraction to form the more reactive hydrox-
yl radical. In ISO induced rats, the activities 
of heart tissue antioxidant enzymes were 
decreased. During MI, SOD and CAT are 
structurally and functionally impaired by 
free radicals resulting in myocardial dam-
age. The decrease in SOD and catalase may 
be due to the involvement of superoxide 
and hydrogen peroxide free radicals in my-
ocardial cell damage mediated by ISO 
(Guarnieri et al., 1980). Normal activities of 
GSH-dependent enzymes such as GPx, 
GRx, and GST are vital for maintaining the 
antioxidant status. The decreased activity of 
these enzymes in the heart is due to in-
creased LPO in ISO-induced rats. Increased 
LPO resulted in decreased levels of GSH. 
Thus, the decreased levels of GSH resulted 
in decreased activities of GPx, GRx, and 
GST in ISO induced rats. Increasing GSH 
content can prevent cellular damage. Thus, 
the observed increased content of GSH pre-
vented cellular damage and enhanced the 
activities of GSH-dependent enzymes in 
TTFAEt pretreated ISO administered rats. 
The effect of TTFAEt on GSH dependent 
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enzymes and GSH clearly indicates the an-
tioxidant potential of TTFAEt.  
Administration of extract maintained 
normal endogenous antioxidant activity by 
increasing the levels of reduced GSH and 
antioxidant enzymes such as SOD, CAT 
and GPx along with decreased levels of li-
pid peroxidation product MDA by its free 
radical scavenging activity.  
 
CONCLUSION 
Biochemical findings of the present 
study indicate that TTFAEt possesses anti-
oxidant properties in myocardium and pro-
tects against ISO induced MI. The most 
important protective mechanism offered by 
TTFAEt is through its ability to decrease 
lipid profile, lipid peroxidation and in-
creased levels of antioxidant enzymes. 
Thus, TTFAEt has been shown to possess 
cardioprotective activity against ISO in-
duced oxidative stress in rats. 
 
ACKNOWLEDGEMENTS 
The work is supported by grants from 
INSPIRE Fellowship, Department of Sci-
ence and Technology, New Delhi. 
 
REFERENCES 
Allain CC, Poon LS, Chan CS, Richmond 
W, Fu PC. Enzymatic determination of total 
serum cholesterol. Clin Chem 1974;20:470-
5. 
 
Assmann G, Schriewer H, Schmitz G, Hä-
gele EO. Quantification of high-density-
lipoprotein cholesterol by precipitation with 
phosphotungstic acid/MgCl2.Clin Chem 
1983;29:2026-30. 
 
Banerjee SK, Sood S, Dinda AK, Das TK, 
Maulik SK. Chronic oral administration of 
raw garlic protects against isoproterenol-
induced myocardial necrosis in rats. Comp 
Biochem Physiol 2003;136C:377-86. 
 
Beers RF Jr, Sizer IW. A spectrophotomet-
ric method of measuring the breakdown of 
hydrogen peroxide by catalase. J Biol Chem 
1952;195:133-40. 
 
Dhalla NS, Temsah RM, Netticadan T. 
Role of oxidative stress in cardiovascular 
diseases. J Hypertens 2000;18:655-73. 
 
Dhawan S, Kapoor NK, Nityanand S.Effect 
of isoprenaline on lipid profile & cardiac 
enzymes in rats. Indian J Exp Biol. 
1978;16:376-8. 
 
Duncan DB. Multiple range and multiple F 
tests. Biometrics 1955;42:1–42. 
 
Ellman GL. Tissue sulphydryl groups.Arch 
Biochem Biophys 1959;82:70-7. 
 
Friedewald WT, Levy RI, Fredrickson DS. 
Estimation of the concentration of low-
density lipoprotein cholesterol in plasma, 
without use of the preparative ultracentri-
fuge Clin Chem 1972;18:499-502. 
 
Fossati P, Prencipe L. Serum triglycerides 
determined colorimetrically with an en-
zyme that produces hydrogen peroxide. 
Clin Chem 1982;28:2077-80. 
 
Gokkusu C, Mostafazadeh T. Changes of 
oxidative stress in various tissues by long-
term administration of vitamin E in hyper-
cholesterolemic rats. Clin Chim Acta 2003; 
328:155-61. 
 
Guarnieri C, Flamigini F, Caldarera CM. 
Role of oxygen in the cellular damage in-
duced by re-oxygenation of hypoxic heart. J 
Mol Cell Cardiol 1980;12:797-808. 
 
Habig WH, Pabst MJ, Jakoby WB. Gluta-
thione S-transferase. The first enzymatic 
step in mercapturic acid formation. J Biol 
Chem 1974;249:7130-9. 
 
EXCLI Journal 2013;12:373-383 – ISSN 1611-2156 




Kandil O, Radwan NM, Hassan AB, Amer 
AM, El-Banna HA. Extracts and fractions 
of Thymus capitatus exhibit antimicrobial 
activities. J Ethnopharmacol 1994;44:19-
24. 
 
Kareem MA, Krushna GS, Hussain SA, 
Lakshmi Devi K. Effect of aqueous extract 
of nutmeg on hyperglycaemia, hyperlipi-
daemia and cardiac histology associated 
with isoproterenol-induced myocardial in-
farction in rats. Trop J Pharm Res 2009;8: 
337-44. 
 
Karthika P, Rajadurai M, Ganapathy P, 
Kanchana G. Cardioprotective effect of es-
culetin on cardiac marker enzymes and 
membrane bound enzymes in isoproterenol-
induced myocardial infarction in Wistar 
rats. Int J Res Ayurveda Pharm 2011;2: 
1374-9. 
 
Marklund S, Marklund G. Involvement of 
the superoxide anion radical in the autoxi-
dation of pyrogallol and a convenient assay 
for superoxide dismutase. Eur J Biochem 
1974;47:469-74. 
 
Mohanty I,Arya DS, Dinda, A, Talwar KK, 
Joshi S, Gupta SK. Mechanisms of cardio-
protective effect of Withania somnifera in 
experimentally induced myocardial infarc-
tion. Basic Clin Pharmacol Toxicol 2004; 
94:184-90. 
 
Morimoto C, Tsujita T, Sumida S, Okuda 
H. Substrate-dependent lipolysis induced by 
isoproterenol. Biochem Biophys Res Com-
mun 2000;274:631-4. 
 
Nirmala C, Puvanakrishnan R. Effect of 
curcumin on certain lysosomal hydrolases 
in isoproterenol-induced myocardial infarc-
tion in rats. Biochem Pharmacol 1996; 51: 
47-51. 
 
Osadchii OE, Norton GR, McKechnie R, 
Deftereos D, Woodiwiss AJ. Cardiac dilata-
tion and pump dysfunction without intrinsic 
myocardial systolic failure following chron-
ic beta-adrenoreceptor activation. Am J 
Physiol 2007;292:H1898-905. 
 
Pinto RE, Bartley W. The effect of age and 
sex on glutathione reductase and glutathi-
one peroxidase activities and on aerobic 
glutathione oxidation in rat liver homoge-
nates. Biochem J 1969;112:109-15. 
 
Radhiga T, Rajamanickam C, Senthil S, 
Pugalendi KV. Effect of Ursolic acid on 
cardiac marker enzymes, lipid profile and 
macroscopic enzyme mapping assay in iso-
proterenol-induced myocardial ischemic 
rats. Food Chem Toxicol 2012;50;3971-7. 
 
Rotruck JT, Pope AL, Ganther HE, Swan-
son AB, Hafeman DG, Hoekstra WG. Sele-
nium: biochemical role as a component of 
glutathione peroxidase. Science 1973;179 
(4073):588-90. 
 
Rupp H, Dhalla KS, Dhalla NSJ. Mecha-
nisms of cardiac cell damage due to cate-
cholamines: significance of drugs regulat-
ing central sympathetic outflow. J Cardio-
vasc Pharmacol 1994;24(Suppl 1):S16-24. 
 
Sathish V, Ebenezar KK, Devaki T. Syner-
gistic effect of nicorandil and amlodipine 
on tissue defense system during experi-
mental myocardial infarction in rats. Mol 
Cell Biochem 2003;243:133-8. 
 
Soon YY, Tan BK. Evaluation of the hypo-
glycemic and anti-oxidant activities of 
Morinda officinalis in Streptozotocin-
induced diabetic rats. Singapore Med J 
2002;43:77-85. 
 
Upaganlawar A, Gandhi H, Balaraman R. 
Isoproterenol induced myocardial infarc-
tion: protective role of natural products. J 
Pharmacol Toxicol 2011;6(1):1-17. 
 
EXCLI Journal 2013;12:373-383 – ISSN 1611-2156 




Utley HG, Bernheim F, Hochstein P. Effect 
of sulfhydryl reagents on peroxidation in 
microsomes.Arch Biochem Biophys 1967; 
118:29-32. 
 
Vaage J, Valen G. Pathophysiology and 
mediators of ischemia-reperfusion injury 
with special reference to cardiac surgery. 
Scand J Thorac Cardiovasc Surg 1993 
(Suppl);41:1-18. 
 
Wang Y, Ohtai K, Kasai R, Yamasaki 
K.Steroidal saponins from fruits of Tribulus 
terrestris. Phytochemistry 1997;45:811-7. 
 
Warrier PK, Nambiar VPK, Ramankutty C 
(eds.): Indian medicinal plants. A compen-
dium of 500 species. Vol. 5 (Tribulus ter-
restris Linn, pp 311-5). Chennai, India: Ori-
ent Longman, 1996. 
 
Wexler BC. Myocardial infarction in young 
vs old male rats: pathophysiologic changes. 
Am Heart J 1978; 96: 70-80. 
 
